FDA Inspection
Park Avenue CompoundingPark Avenue Compounding – FDA Inspection, Nov 16, 2017
Record Details
This FDA Inspection record concerns Park Avenue Compounding, with an inspection on November 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1df0561a-e508-4240-92be-80f6c8e35bf4
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1033886
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Park Avenue Compounding
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| February 8, 2024 | OAI | Drug Quality Assurance | |
| August 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Park Avenue Compounding
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.